Search

everythinglearnresearchcommunity

for

Search:↓

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Cinchonine Nanostructured Lipid Carriers serum safely and effectively stimulates hair growth and increases the number and size of hair follicles.

Magistral pharmacies had issues with production quality and dosage accuracy.

Finasteride is popular for treating male hair loss but may increase the risk of serious prostate cancer and has other potential side effects.

Europe strengthened medicine regulations, increased protection against counterfeit drugs, and made it tougher to challenge comparative advertising, while also focusing on patent law enforcement and updating plant protection rules.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.

Effervescent formulations may improve minoxidil delivery, increasing effectiveness and reducing applications needed.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Chemicals from the plant Dicerocaryum senecioides were found to safely speed up and increase hair growth in mice.

Finasteride effectively treats male hair loss, increasing length and thickness.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

Taking calcium may help elderly with osteoporosis, birth control with levonorgestrel doesn't increase heart attack risk, Salmonella can cause arthritis, a national ethics committee is recommended, and sulfasalazine might help with a hair loss condition.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Low iron and L-lysine levels can cause hair loss in women, and increasing these nutrients can reduce hair shedding.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

A special dressing called FEA-PCEI can speed up wound healing, reduce scars, and help grow new hair follicles, but only at the right dosage.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

Injections with 0.5% minoxidil effectively treat female hair loss, increasing hair density and thickness.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

N-acetyl-cysteine shows promise in treating various diseases and may improve skin and hair conditions, but more research is needed on dosages and long-term effects.

A woman's unique dementia was misdiagnosed, a genetic mutation increases Parkinson's risk with age, and finasteride may help with Tourette syndrome.

Finasteride lowers good cholesterol, raises bad fats, and may increase heart disease risk.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.